A citation-based method for searching scientific literature

J J Holst. Int J Obes (Lond) 2013
Times Cited: 93







List of co-cited articles
1151 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The physiology of glucagon-like peptide 1.
Jens Juul Holst. Physiol Rev 2007
26

Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study.
Arne Astrup, Stephan Rössner, Luc Van Gaal, Aila Rissanen, Leo Niskanen, Mazin Al Hakim, Jesper Madsen, Mads F Rasmussen, Michael E J Lean. Lancet 2009
610
16

A role for glucagon-like peptide-1 in the central regulation of feeding.
M D Turton, D O'Shea, I Gunn, S A Beak, C M Edwards, K Meeran, S J Choi, G M Taylor, M M Heath, P D Lambert,[...]. Nature 1996
11

Gut hormone PYY(3-36) physiologically inhibits food intake.
Rachel L Batterham, Michael A Cowley, Caroline J Small, Herbert Herzog, Mark A Cohen, Catherine L Dakin, Alison M Wren, Audrey E Brynes, Malcolm J Low, Mohammad A Ghatei,[...]. Nature 2002
11

Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass.
Carel W le Roux, Richard Welbourn, Malin Werling, Alan Osborne, Alexander Kokkinos, Anna Laurenius, Hans Lönroth, Lars Fändriks, Mohammad A Ghatei, Stephen R Bloom,[...]. Ann Surg 2007
488
11

Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans.
M A Nauck, U Niedereichholz, R Ettler, J J Holst, C Orskov, R Ritzel, W H Schmiegel. Am J Physiol 1997
504
10

Biology of incretins: GLP-1 and GIP.
Laurie L Baggio, Daniel J Drucker. Gastroenterology 2007
10


Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide.
A Astrup, R Carraro, N Finer, A Harper, M Kunesova, M E J Lean, L Niskanen, M F Rasmussen, A Rissanen, S Rössner,[...]. Int J Obes (Lond) 2012
326
9

Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials.
Tina Vilsbøll, Mikkel Christensen, Anders E Junker, Filip K Knop, Lise Lotte Gluud. BMJ 2012
497
9

Evidence that intestinal glucagon-like peptide-1 plays a physiological role in satiety.
Diana L Williams, Denis G Baskin, Michael W Schwartz. Endocrinology 2009
209
9

Cholecystokinin decreases food intake in rats.
J Gibbs, R C Young, G P Smith. J Comp Physiol Psychol 1973
9

Inhibition of food intake in obese subjects by peptide YY3-36.
Rachel L Batterham, Mark A Cohen, Sandra M Ellis, Carel W Le Roux, Dominic J Withers, Gary S Frost, Mohammad A Ghatei, Stephen R Bloom. N Engl J Med 2003
9


Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn,[...]. N Engl J Med 2016
9

Glucose sensing in L cells: a primary cell study.
Frank Reimann, Abdella M Habib, Gwen Tolhurst, Helen E Parker, Gareth J Rogers, Fiona M Gribble. Cell Metab 2008
502
8


Multicenter, placebo-controlled trial of lorcaserin for weight management.
Steven R Smith, Neil J Weissman, Christen M Anderson, Matilde Sanchez, Emil Chuang, Scott Stubbe, Harold Bays, William R Shanahan. N Engl J Med 2010
572
8

Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
T Vilsbøll, T Krarup, J Sonne, S Madsbad, A Vølund, A G Juul, J J Holst. J Clin Endocrinol Metab 2003
363
8

The role of postprandial releases of insulin and incretin hormones in meal-induced satiety--effect of obesity and weight reduction.
C Verdich, S Toubro, B Buemann, J Lysgård Madsen, J Juul Holst, A Astrup. Int J Obes Relat Metab Disord 2001
287
8

Inhibition of gastric inhibitory polypeptide signaling prevents obesity.
Kazumasa Miyawaki, Yuichiro Yamada, Nobuhiro Ban, Yu Ihara, Katsushi Tsukiyama, Heying Zhou, Shimpei Fujimoto, Akira Oku, Kinsuke Tsuda, Shinya Toyokuni,[...]. Nat Med 2002
600
8


Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP.
Michael J Theodorakis, Olga Carlson, Spyros Michopoulos, Máire E Doyle, Magdalena Juhaszova, Kalliopi Petraki, Josephine M Egan. Am J Physiol Endocrinol Metab 2006
252
8



Liraglutide as additional treatment for type 1 diabetes.
Ajay Varanasi, Natalie Bellini, Deepti Rawal, Mehul Vora, Antoine Makdissi, Sandeep Dhindsa, Ajay Chaudhuri, Paresh Dandona. Eur J Endocrinol 2011
97
8

Type 1 diabetes treatment beyond insulin: role of GLP-1 analogs.
Lindsay B Harrison, Pablo F Mora, Gregory O Clark, Ildiko Lingvay. J Investig Med 2013
35
22

A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management.
Xavier Pi-Sunyer, Arne Astrup, Ken Fujioka, Frank Greenway, Alfredo Halpern, Michel Krempf, David C W Lau, Carel W le Roux, Rafael Violante Ortiz, Christine Bjørn Jensen,[...]. N Engl J Med 2015
686
8

Twelve-Week Treatment With Liraglutide as Add-on to Insulin in Normal-Weight Patients With Poorly Controlled Type 1 Diabetes: A Randomized, Placebo-Controlled, Double-Blind Parallel Study.
Christian S Frandsen, Thomas F Dejgaard, Jens J Holst, Henrik U Andersen, Birger Thorsteinsson, Sten Madsbad. Diabetes Care 2015
50
16

Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial.
Thomas Fremming Dejgaard, Christian Seerup Frandsen, Tanja Stenbæk Hansen, Thomas Almdal, Søren Urhammer, Ulrik Pedersen-Bjergaard, Tonny Jensen, Andreas Kryger Jensen, Jens Juul Holst, Lise Tarnow,[...]. Lancet Diabetes Endocrinol 2016
71
11


Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms.
N Imeryüz, B C Yeğen, A Bozkurt, T Coşkun, M L Villanueva-Peñacarrillo, N B Ulusoy. Am J Physiol 1997
261
7


Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2.
Gwen Tolhurst, Helen Heffron, Yu Shan Lam, Helen E Parker, Abdella M Habib, Eleftheria Diakogiannaki, Jennifer Cameron, Johannes Grosse, Frank Reimann, Fiona M Gribble. Diabetes 2012
928
7

Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120.
Akira Hirasawa, Keiko Tsumaya, Takeo Awaji, Susumu Katsuma, Tetsuya Adachi, Masateru Yamada, Yukihiko Sugimoto, Shunichi Miyazaki, Gozoh Tsujimoto. Nat Med 2005
988
7

The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway.
Caroline R Abbott, Mariana Monteiro, Caroline J Small, Arshia Sajedi, Kirsty L Smith, James R C Parkinson, Mohammad A Ghatei, Stephen R Bloom. Brain Res 2005
387
7


Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6).
John B Buse, Julio Rosenstock, Giorgio Sesti, Wolfgang E Schmidt, Eduard Montanya, Jason H Brett, Marcin Zychma, Lawrence Blonde. Lancet 2009
7

Gastrointestinal regulation of food intake.
David E Cummings, Joost Overduin. J Clin Invest 2007
700
7

Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man.
R Eissele, R Göke, S Willemer, H P Harthus, H Vermeer, R Arnold, B Göke. Eur J Clin Invest 1992
439
7

Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass.
C Dirksen, N B Jørgensen, K N Bojsen-Møller, U Kielgast, S H Jacobsen, T R Clausen, D Worm, B Hartmann, J F Rehfeld, M Damgaard,[...]. Int J Obes (Lond) 2013
156
7


Central nervous system control of food intake.
M W Schwartz, S C Woods, D Porte, R J Seeley, D G Baskin. Nature 2000
7

Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.
A Flint, A Raben, A Astrup, J J Holst. J Clin Invest 1998
909
7

Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms.
Elisabeth B Rüttimann, Myrtha Arnold, Jacquelien J Hillebrand, Nori Geary, Wolfgang Langhans. Endocrinology 2009
191
7

Neuronal GLP1R mediates liraglutide's anorectic but not glucose-lowering effect.
Stephanie Sisley, Ruth Gutierrez-Aguilar, Michael Scott, David A D'Alessio, Darleen A Sandoval, Randy J Seeley. J Clin Invest 2014
194
7

Design of the liraglutide effect and action in diabetes: evaluation of cardiovascular outcome results (LEADER) trial.
Steven P Marso, Neil R Poulter, Steven E Nissen, Michael A Nauck, Bernard Zinman, Gilbert H Daniels, Stuart Pocock, William M Steinberg, Richard M Bergenstal, Johannes F E Mann,[...]. Am Heart J 2013
138
7


GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans.
Liselotte van Bloemendaal, Richard G IJzerman, Jennifer S Ten Kulve, Frederik Barkhof, Robert J Konrad, Madeleine L Drent, Dick J Veltman, Michaela Diamant. Diabetes 2014
158
7

The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss.
Anna Secher, Jacob Jelsing, Arian F Baquero, Jacob Hecksher-Sørensen, Michael A Cowley, Louise S Dalbøge, Gitte Hansen, Kevin L Grove, Charles Pyke, Kirsten Raun,[...]. J Clin Invest 2014
352
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.